ANNOVIS BIO INC. COMMON STOCK
1,7000
12-марта-25 16:30:00
15 мин. задержка
Акции
+0,1000
+6,25%
Сегодняшний диапазон
1,5700 - 1,7200
ISIN
N/A
Источник
NYSE
- Котировки
- Графики
Новости
- Статистика
-
Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist
06 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap
24 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
16 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
09 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
02 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
27 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
26 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
25 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
18 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
11 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Announces New Publication in a Peer-Reviewed Journal
21 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
13 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
09 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
06 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
29 апр 2024 10:10:00 Источник Nasdaq GlobeNewswire
-
02 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
01 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
20 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
27 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
14 фев 2024 07:30:00 Источник Nasdaq GlobeNewswire